TipRanks
Advertisement
Advertisement
Danaher call volume above normal and directionally bullish
PremiumThe FlyDanaher call volume above normal and directionally bullish
4d ago
Danaher price target raised to $250 from $215 at RBC Capital
Premium
The Fly
Danaher price target raised to $250 from $215 at RBC Capital
4d ago
Danaher price target raised to $250 from $200 at Guggenheim
Premium
The Fly
Danaher price target raised to $250 from $200 at Guggenheim
8d ago
Danaher’s IDT, Aldevron launch research grade S.p. Cas9 mRNA, SpyFi
PremiumThe FlyDanaher’s IDT, Aldevron launch research grade S.p. Cas9 mRNA, SpyFi
23d ago
Danaher assumed with a Buy at UBS
Premium
The Fly
Danaher assumed with a Buy at UBS
1M ago
Wells sees Repligen among key beneficiaries of Moderna’s cancer vaccine data
Premium
The Fly
Wells sees Repligen among key beneficiaries of Moderna’s cancer vaccine data
2M ago
Danaher: Temporary Bioprocessing Setback, Structural Story Intact; Buy Rating and $220 Price Target Reiterated
PremiumRatingsDanaher: Temporary Bioprocessing Setback, Structural Story Intact; Buy Rating and $220 Price Target Reiterated
2M ago
Danaher’s recent volatility presents buying opportunity, says Argus
Premium
The Fly
Danaher’s recent volatility presents buying opportunity, says Argus
3M ago
Goldman’s Koslosky Reiterates Buy on Danaher as Q2 Beat and Tools Recovery Offset Trimmed 2024 Core Growth Guidance
Premium
Ratings
Goldman’s Koslosky Reiterates Buy on Danaher as Q2 Beat and Tools Recovery Offset Trimmed 2024 Core Growth Guidance
3M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―